Sylviane Ragot

487 total citations
18 papers, 358 citations indexed

About

Sylviane Ragot is a scholar working on Physiology, Biological Psychiatry and Genetics. According to data from OpenAlex, Sylviane Ragot has authored 18 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 4 papers in Biological Psychiatry and 4 papers in Genetics. Recurrent topics in Sylviane Ragot's work include Telomeres, Telomerase, and Senescence (5 papers), Tryptophan and brain disorders (4 papers) and Genetics, Aging, and Longevity in Model Organisms (3 papers). Sylviane Ragot is often cited by papers focused on Telomeres, Telomerase, and Senescence (5 papers), Tryptophan and brain disorders (4 papers) and Genetics, Aging, and Longevity in Model Organisms (3 papers). Sylviane Ragot collaborates with scholars based in France, United Kingdom and Canada. Sylviane Ragot's co-authors include Jean‐Christophe Chauvet‐Gélinier, Bernard Bonin, Jean‐Raymond Teyssier, J. Teyssier, Michel Benoît, Benoît Trojak, Rory McCulloch, Catherine Vergely, Franck Morschhauser and Mary Callanan and has published in prestigious journals such as Blood, PLoS ONE and Journal of Affective Disorders.

In The Last Decade

Sylviane Ragot

18 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylviane Ragot France 11 118 92 71 68 62 18 358
Lauren Broestl United States 9 97 0.8× 164 1.8× 37 0.5× 32 0.5× 14 0.2× 11 541
Alexanne Cuillerier Canada 11 94 0.8× 303 3.3× 33 0.5× 35 0.5× 19 0.3× 25 503
Thomas Groves United States 12 93 0.8× 100 1.1× 24 0.3× 52 0.8× 18 0.3× 17 377
Tomonori Yonezu Japan 10 183 1.6× 267 2.9× 17 0.2× 18 0.3× 15 0.2× 11 453
José C. Utrilla Spain 13 51 0.4× 123 1.3× 57 0.8× 8 0.1× 20 0.3× 27 467
Jvalini Dwarkasing Netherlands 11 155 1.3× 150 1.6× 17 0.2× 7 0.1× 18 0.3× 22 406
Alisha A. McBride United States 7 110 0.9× 113 1.2× 4 0.1× 28 0.4× 28 0.5× 11 366
Maggie Lai United Kingdom 9 35 0.3× 138 1.5× 21 0.3× 28 0.4× 19 0.3× 12 512
Ya-Li Zheng China 13 72 0.6× 217 2.4× 19 0.3× 16 0.2× 19 0.3× 29 454
Roberta Zerlotin Italy 13 274 2.3× 173 1.9× 18 0.3× 11 0.2× 20 0.3× 30 432

Countries citing papers authored by Sylviane Ragot

Since Specialization
Citations

This map shows the geographic impact of Sylviane Ragot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylviane Ragot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylviane Ragot more than expected).

Fields of papers citing papers by Sylviane Ragot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylviane Ragot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylviane Ragot. The network helps show where Sylviane Ragot may publish in the future.

Co-authorship network of co-authors of Sylviane Ragot

This figure shows the co-authorship network connecting the top 25 collaborators of Sylviane Ragot. A scholar is included among the top collaborators of Sylviane Ragot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylviane Ragot. Sylviane Ragot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Gouill, Steven Le, Franck Morschhauser, David Chiron, et al.. (2020). Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lymphoma: a phase 1/2 trial. Blood. 137(7). 877–887. 75 indexed citations
3.
Aral, Bernard, et al.. (2018). Germline JAK2 L611S mutation in a child with thrombocytosis. Haematologica. 103(8). e372–e373. 8 indexed citations
4.
Rey, Romain, Jean‐Christophe Chauvet‐Gélinier, Marie‐Françoise Suaud‐Chagny, et al.. (2018). Distinct Expression Pattern of Epigenetic Machinery Genes in Blood Leucocytes and Brain Cortex of Depressive Patients. Molecular Neurobiology. 56(7). 4697–4707. 17 indexed citations
5.
Chauvet‐Gélinier, Jean‐Christophe, Cédric Lemogne, Sylviane Ragot, et al.. (2018). Type A competitiveness traits correlate with downregulation of c-Fos expression in patients with type 1 diabetes. Diabetes & Metabolism. 45(6). 582–585. 3 indexed citations
6.
Wiedemann, Andreas, Shyue-Fang Battaglia-Hsu, L. Mainard, et al.. (2016). 30 months follow-up of an early enzyme replacement therapy in a severe Morquio A patient: About one case. Molecular Genetics and Metabolism Reports. 9. 42–45. 25 indexed citations
7.
Marle, Nathalie, Anne‐Laure Mosca‐Boidron, Laurence Faivre, et al.. (2015). 6q16.3q23.3 duplication associated with Prader-Willi-like syndrome. Molecular Cytogenetics. 8(1). 42–42. 8 indexed citations
8.
Teyssier, Jean‐Raymond, et al.. (2014). Telomeres in the Brain Cortex of Patients with Major Depressive Disorder. 56(3). 89–94. 1 indexed citations
9.
Teyssier, Jean‐Raymond, Romain Rey, Sylviane Ragot, Jean‐Christophe Chauvet‐Gélinier, & Bernard Bonin. (2013). Correlative gene expression pattern linking RNF123 to cellular stress–senescence genes in patients with depressive disorder: Implication of DRD1 in the cerebral cortex. Journal of Affective Disorders. 151(2). 432–438. 10 indexed citations
10.
Teyssier, J., Jean‐Christophe Chauvet‐Gélinier, Sylviane Ragot, & Bernard Bonin. (2012). Up-Regulation of leucocytes Genes Implicated in Telomere Dysfunction and Cellular Senescence Correlates with Depression and Anxiety Severity Scores. PLoS ONE. 7(11). e49677–e49677. 56 indexed citations
11.
Biotti, Damien, Serge Aho, Yannick Béjot, et al.. (2012). Leukocyte Telomere Length: A Focus on Cerebrovascular Events. Rejuvenation Research. 15(3). 274–280. 4 indexed citations
12.
Teyssier, Jean‐Raymond, Catherine Vergely, Luc Lorgis, et al.. (2011). Smoking and FOS expression from blood leukocyte transcripts in patients with coronary artery disease. Atherosclerosis. 219(2). 931–936. 12 indexed citations
13.
Teyssier, Jean‐Raymond, Catherine Vergely, Luc Lorgis, et al.. (2011). Circulating leukocyte telomere length and oxidative stress: A new target for statin therapy. Atherosclerosis. 219(2). 753–760. 43 indexed citations
14.
Teyssier, Jean‐Raymond, Sylviane Ragot, Jean‐Christophe Chauvet‐Gélinier, Benoît Trojak, & Bernard Bonin. (2011). Activation of a ΔFOSB dependent gene expression pattern in the dorsolateral prefrontal cortex of patients with major depressive disorder. Journal of Affective Disorders. 133(1-2). 174–178. 25 indexed citations
15.
Teyssier, Jean‐Raymond, et al.. (2010). Longueur des télomères dans le cortex des patients atteints de troubles dépressifs. L Encéphale. 36(6). 491–494. 17 indexed citations
16.
Teyssier, Jean‐Raymond, Sylviane Ragot, Jean‐Christophe Chauvet‐Gélinier, Michel Benoît, & Bernard Bonin. (2010). Expression of oxidative stress-response genes is not activated in the prefrontal cortex of patients with depressive disorder. Psychiatry Research. 186(2-3). 244–247. 35 indexed citations
17.
Mosca, A.L., Patrick Callier, Laurence Faivre, et al.. (2009). Polymicrogyria in a child with inv dup del(9p) and 22q11.2 microduplication. American Journal of Medical Genetics Part A. 149A(3). 475–481. 13 indexed citations
18.
Donal, Erwan, et al.. (2001). [Systemic markers of inflammation after coronary angioplasty].. PubMed. 30(34). 1701–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026